COMMUNIQUÉS West-GlobeNewswire

Genocea’s GEN-009 Clinical Results Presentation Selected by ASCO’s Journal of Clinical Oncology® as a Top 10 Featured Immuno-oncology Abstract
31/05/2019
Poster presentation tomorrow, June 1 st at 8:00 am CT in Poster Hall A Conference call and webcast to discuss results Monday, June 3 rd at 8:30 am ET CAMBRIDGE, Mass., May 31, 2019 (GLOBE NEWSWIRE) -- Genocea [...]
Aptose to Present at the Jefferies 2019 Healthcare Conference
31/05/2019
SAN DIEGO and TORONTO, May 31, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage biotechnology company developing first-in-class agents that target the dysregulated processes [...]
ContraVir Pharmaceuticals, Inc. Announces Reverse Stock Split
31/05/2019
Reverse stock split intended to bring company into compliance with minimum bid price requirement for maintaining listing on Nasdaq Capital Market EDISON, N.J., May 31, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals [...]
YSS Corp.™ (formerly Solo Growth Corp.) Announces 2019 Construction Update, Name Change to YSS Corp and New Corporate Presentation
31/05/2019
CALGARY, Alberta, May 31, 2019 (GLOBE NEWSWIRE) -- YSS Corp.™ (TSXV: SOLO) (WKN:A2PBMC) (formerly Solo Growth Corp.), a cannabis retailer operating as YSS TM with the vision to become a premier retailer and the trusted [...]
BioCryst to Present at Upcoming Investor Conferences
31/05/2019
RESEARCH TRIANGLE PARK, N.C., May 31, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the Jefferies 2019 Healthcare Conference in New York on [...]
Updated Results of Studies in Advanced Cervical Cancer and Melanoma Support Long-Term Efficacy of Iovance Tumor Infiltrating Lymphocyte (TIL) Therapy
31/05/2019
Complete Response rate of 11 percent observed in the LN-145 study in cervical cancer Median duration of response has not been reached at 7.4 month median follow-up in the ongoing study of LN-145 in advanced cervical [...]
Cara Therapeutics to Present at the Jefferies 2019 Healthcare Conference
31/05/2019
STAMFORD, Conn., May 31, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities with a primary focus on pruritus by [...]
Axovant to Present at Upcoming Conferences in June
31/05/2019
BASEL, Switzerland, May 31, 2019 (GLOBE NEWSWIRE) -- Axovant Gene Therapies Ltd. (Nasdaq: AXGT), a clinical-stage company developing innovative gene therapies, today announced that Pavan Cheruvu, M.D., chief executive [...]
ContraFect Announces Publication of Paper on Recent Exebacase Data in Antimicrobial Agents and Chemotherapy Journal
31/05/2019
Exebacase concentrations below the minimum inhibitory concentration (sub-MIC) demonstrated sustained reductions in bacterial fitness and virulence of Staphylococcus aureus YONKERS, N.Y., May 31, 2019 (GLOBE NEWSWIRE [...]
Iovance Biotherapeutics to Participate in Upcoming Conferences in June
31/05/2019
SAN CARLOS, Calif., May 31, 2019 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]
Herantis Pharma Oyj: Manager’s Transactions - Pekka Mattila
31/05/2019
Herantis Pharma Oyj: Manager’s Transactions - Pekka Mattila Herantis Pharma Plc Company release 31 May 2019 at 1:00 pm Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Herantis Pharma Oyj: Manager’s Transactions - Timo Veromaa
31/05/2019
Herantis Pharma Oyj: Manager’s Transactions - Timo Veromaa Herantis Pharma Plc Company release 31 May 2019 at 1:00 pm Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Herantis Pharma Oyj: Manager’s Transactions - Frans Wuite
31/05/2019
Herantis Pharma Oyj: Manager’s Transactions - Frans Wuite Herantis Pharma Plc Company release 31 May 2019 at 1:00 pm Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Amphastar Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference
31/05/2019
RANCHO CUCAMONGA, Calif., May 31, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell, President and Bill Peters, CFO, will be presenting at the Jefferies 2019 [...]
Herantis Pharma Oyj: Manager’s Transactions - Pekka Simula
31/05/2019
Herantis Pharma Oyj: Manager’s Transactions - Pekka Simula Herantis Pharma Plc Company release 31 May 2019 at 1:00 pm Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Herantis Pharma Oyj: Manager’s Transactions - James Phillips
31/05/2019
Herantis Pharma Oyj: Manager’s Transactions - James Phillips Herantis Pharma Plc Company release 31 May 2019 at 1:00 pm Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person [...]
Herantis Pharma Oyj: Manager’s Transactions - Inveni Life Sciences Fund I Ky
31/05/2019
Herantis Pharma Oyj: Manager’s Transactions - Inveni Life Sciences Fund I Ky Herantis Pharma Plc Company release 31 May 2019 at 1:00 pm Herantis Pharma Oyj - Managers' Transactions [...]
ASLAN Pharmaceuticals Acquires Full Global Commercial Rights for ASLAN004 From CSL
31/05/2019
- Amending their previous agreement, CSL grants ASLAN full global rights to develop, manufacture and commercialise ASLAN004 SINGAPORE, May 31, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a [...]
Oncology Venture publishes Q1 report for 2019
31/05/2019
Company Announcement Hoersholm, Denmark – May 31, 2019 – Oncology Venture A/S (OV:ST) (“Oncology Venture”) today publishes the Interim Report for the first quarter of 2019. The Interim Report is available as an attached [...]

Pages